Business Wire

Alcon Introduces AcrySof IQ PanOptix Trifocal IOL in the U.S., the First and Only FDA-Approved Trifocal Lens

PanOptix delivers an exceptional combination of near, intermediate and distance vision and substantially reduces the need for glasses 1,2 More than ninety-nine percent of PanOptix patients in the FDA ...
WKRN-TV

Take 2: PanOptix lens implant corrects vision in 3 ways

It’s the first FDA approved trifocal lens implant to correct vision in three ways. It’s called PanOptix. Ophthalmologist Dr. Jeffery Horn of Vision for Life in Nashville was part of the clinical study ...
KPLC

FDA approves tri-focal lenses for cataract patients

LAKE CHARLES, La. (KPLC) - Cataracts affect more than 24 million Americans over the age of 40, but now those in the U.S have the chance to try a new FDA approved lens. Over the last few years, Steve ...
Seeking Alpha

Alcon Expands Leadership in IOL Innovation with Clareon PanOptix Pro, Delivering Best-in-Class Light Utilization and Less Light Scatter

GENEVA--(BUSINESS WIRE)-- Alcon (ALC), the global leader in eye care dedicated to helping people see brilliantly, announced today the introduction of Clareon ® PanOptix ® Pro intraocular lens (IOL) ...
The Financial

Alcon AcrySof IQ PanOptix trifocal intraocular lens shows superior visual performance in head-to-head trial post-cataract surgery

The FINANCIAL — Basel, June 18, 2018 Alcon, the global leader in eye care and a division of Novartis, unveils new data showing significantly improved near and intermediate distance vision with the ...
Hosted on MSN

Alcon Inc (ALC) Announces Approval of Clareon PanOptix Pro Intraocular Lens

Alcon Inc. (NYSE:ALC) is one of the 11 Best 52-Week Low Stocks to Buy Right Now. On June 20, Alcon Inc. (NYSE:ALC) announced the approval of the Clareon PanOptix Pro intraocular lens for patients in ...